How egg-freezing is keeping more women in the tech industry: The inside story
By Alison DeNisco,
Tech Republic [cites CGS' Marcy Darnovsky]
| 08. 15. 2017
Women leave jobs at mid-career in tech at higher rates than those in other fields. It's possible that benefits like egg freezing can improve female retention, but the procedure remains controversial.
At Brigitte Adams' last job in tech, an office lactation room was turned into a prayer room. "There were no pregnant women at the company, ever," she said. "I was surrounded by men in engineering departments. You didn't see other women."
In the summer of 2011, Adams had just left a multinational corporation to become a consultant. She was 39 years old and not yet married, and began thinking about making plans for a future family. "It was sort of a typical scenario of a single career woman who really wanted kids," she said. Being a tech-minded person, she turned to a procedure that was at the time still labeled experimental: Egg freezing. Also known as oocyte cryopreservation, egg freezing is a process in which a woman's eggs are extracted, frozen, and stored for future use, as a way to preserve their reproductive potential.
It's been nearly three...
Related Articles
By Rhys Blakely, The Times | 06.24.2025
Scientists have created fertile mice from male genetic material alone, a breakthrough that could one day open the door to human babies who inherit their genes from two fathers.
The experiment, led by Professor Yanchang Wei at Shanghai Jiao Tong...
By Ron Leuty, San Francisco Business Times | 06.16.2025
23andMe's two-step sale to a nonprofit led by former CEO Anne Wojcicki is nothing more than a dance around California's genetic privacy law, state Attorney General Rob Bonta said in a filing late Monday, one day before a judge will...
By Angus Liu, Fierce Pharma | 06.16.2025
A second patient has died following treatment with Sarepta Therapeutics’ Elevidys, raising more doubts about the Duchenne muscular dystrophy (DMD) gene therapy’s safety profile.
Sarepta and its ex-U.S. partner Roche reported the death early Sunday. Like the first case, disclosed...
By Gina Kolata, The New York Times | 06.20.2025
A single infusion of a stem cell-based treatment may have cured 10 out of 12 people with the most severe form of type 1 diabetes. One year later, these 10 patients no longer need insulin. The other two patients need...